TheFly.com
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
GANX
Gain Therapeutics
$
()
GANX
Gain Therapeutics price target raised to $6 from $5.75 at Chardan
GANX
5/14/2023 - 20:43pm
Gain Therapeutics expects cash to fund operations into 3Q24
GANX
5/12/2023 - 08:08am
Gain Therapeutics reports Q1 EPS (43c), consensus (39c)
GANX
5/12/2023 - 08:07am
Gain Therapeutics awarded CHF 2.5M Innosuisse grant
GANX
5/3/2023 - 09:17am
Gain Therapeutics appoints C. Evan Ballantyne as CFO
GANX
4/12/2023 - 16:40pm
Gain Therapeutics presents preclinical data from GBA1 Program
GANX
3/29/2023 - 08:55am
Oppenheimer biotechnology analysts to hold an analyst/industry conference call
GANX
3/29/2023 - 04:55am
Oppenheimer biotechnology analysts to hold an analyst/industry conference call
GANX
3/28/2023 - 16:19pm
Gain Therapeutics price target raised to $5.75 from $4 at Chardan
GANX
3/27/2023 - 04:25am
Gain sees dossier submission for Phase 1 clinical trial of GT-0228 by mid 2023
GANX
3/23/2023 - 17:53pm
Gain Therapeutics sees completion of IND enabling studies of GT-02287 in 1H 2023
GANX
3/23/2023 - 17:50pm
Gain Therapeutics reports FY22 EPS ($1.48), consensus ($1.51)
GANX
3/23/2023 - 16:39pm
Gain Therapeutics announces grant award by Eurostars with Innosuisse
GANX
3/21/2023 - 08:14am
Gain Therapeutics presents preclinical data from Gaucher Disease Program
GANX
2/27/2023 - 08:08am
Gain Therapeutics initiated with a Buy at Chardan
GANX
12/9/2022 - 07:06am
dynamic_feed
Breaking News
search
Search
menu
Menu